Fig. 3From: Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary interventionCumulative incidence plots of MACE and each component of MACE stratified by the DAPA administration. A MACE; B overall death; C non-fatal stroke; D heart failure; E non-fatal MI; F URR. MACE: major adverse cardiovascular events; MI: myocardial infarction; URR: unplanned repeat revascularization.Back to article page